Patient Engagement in a Multi-Stakeholder Workshop to Plan the Collection of Patient-Oriented Outcomes for Children with Inherited Metabolic Diseases.


Journal

Healthcare quarterly (Toronto, Ont.)
ISSN: 1710-2774
Titre abrégé: Healthc Q
Pays: Canada
ID NLM: 101208192

Informations de publication

Date de publication:
Apr 2022
Historique:
entrez: 25 4 2022
pubmed: 26 4 2022
medline: 28 4 2022
Statut: ppublish

Résumé

Building on a study to develop core outcome sets for children with rare inherited metabolic diseases, the purpose of this workshop was to inform the design of longitudinal pediatric registries that support registry-based clinical trials. This workshop was co-designed by two patient/family partner investigators and attended by two family advisors who received preparatory training. Patient partners and advisors recommended integrating the collection of registry data into everyday life and highlighted the importance of transparent communication and attention to the issue of integration of patient-reported data into clinical care. We propose a need to explore strategies for engaging patients in post-project knowledge translation.

Identifiants

pubmed: 35467516
pii: hcq.2022.26769
doi: 10.12927/hcq.2022.26769
pii:
doi:

Types de publication

Journal Article

Langues

eng

Pagination

81-85

Informations de copyright

Copyright © 2022 Longwoods Publishing.

Auteurs

Kylie Tingley (K)

An epidemiologist from the University of Ottawa. Kylie's research has focused on evidence generation and synthesis for rare diseases and their associated treatments.

Maureen Smith (M)

A patient partner whose interest in partnerships with researchers stems from her diagnosis with a rare disease in childhood.

Nicole Pallone (N)

A mother of a teenager diagnosed with PKU and served as the vice president of Canadian PKU and Allied Disorders Inc. for six years and as a board member for 10 years.

Pranesh Chakraborty (P)

A medical biochemist and pediatrician with clinical and research activities in the treatment of children with inherited metabolic diseases. Pranesh is also the chief medical officer of Newborn Screening Ontario.

Beth K Potter (BK)

Leads a research program that aims to generate evidence to improve health outcomes and experiences with care for children with rare diseases and their families. Beth can be contacted by e-mail at bpotter@uottawa.ca.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH